PBOC Eases Traders’ Liquidity Fears Leading To Growth Rebound

Health care had a strong day in Hong Kong and Mainland China as Cansino Biologics gained +17% after announcing strong phase 3 coronavirus clinical trials.

Leave a Comment

Your email address will not be published.

This site uses Akismet to reduce spam. Learn how your comment data is processed.